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synthesis opens new avenues in biotech-
nology and medicine, far beyond the
development of new antibiotics.
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A surprising link between innate immunity and nuclear reprogramming is reported by Lee et al.; this
discovery may boost the efficiency of stem cell production.Innate immunity primarily involves germ-
line-encoded receptors that recognize
conserved microbial structures, trigger-
ing signaling pathways that induce the
expression of a wide range of proteins
critical for disease resistance. Despite
its ubiquity and importance, the link
between innate immunity and the induc-
tion of pluripotent stem cells uncovered
by Lee et al. (2012) in this issue of Cell
is far from obvious. They demonstrate
that activation of toll-like receptor-3
(TLR3) causes changes in expression of
epigenetic modifiers, thereby facilitating
nuclear reprogramming in the presence
of the transcription factor cocktail con-
sisting of Oct4, Sox2, Klf4, and c-Myc
(Figure 1). This new approach could opti-
mize the induction of pluripotent stem
cells from somatic cells and may pro-
vide a whole new means for stem cell
production.
Landmark studies by Yamanaka (re-
warded with the Nobel Prize for Medicine
of Physiology in 2012) and colleaguesdemonstrated that the expression of four
transcription factors, Oct4, Sox2, Klf4,
and c-Myc (OSKM), could induce pluripo-
tency in somatic cells such as fibroblasts
(Takahashi et al., 2007). This OSKM
protocol was an important breakthrough
in stem cell research, but the mechanism
was uncertain. Retroviral expression of
the proteins led to concerns about inte-
gration into the host genome that might
dysregulate expression of other important
host genes and have deleterious effects,
including cellular transformation. The
OSKM proteins themselves, when ren-
dered cell permeable, could achieve the
same effect, although curiously with
much lower efficiency (Cho et al., 2010).
Lee et al. (2012) address this inefficiency
by first comparing the ability of retrovirally
encoded Sox2 (as a sample OSKM
protein) to cell-permeant Sox2 to induce
pluripotency. Both were applied to fibro-
blasts and downstream targets of Sox2,
such as Jarid2, as well as markers of
nuclear reprogramming, such as Nanog,were measured. Both types of response
are enhanced in response to retrovirally
encoded Sox2, whereas cell-permeant
Sox2 is much less effective. A similar
difference is observed with Oct4. The
authors hypothesized that an intrinsic
feature of viral particles might be respon-
sible for the different efficiencies. They
confirm this by demonstrating that the
viral vector alone, which does not encode
Sox2, when combined with cell-permeant
Sox2 could induce similar gene expres-
sion changes as that induced by the
vector when it encoded Sox2.
Given that certain TLRs sense nucleic
acids (usually derived from microbes),
the authors wondered if TLR activation
might be involved. They examined TLR3
because this is known to sense viral RNA
(Alexopoulou et al., 2001) and so might
sense the retroviral vector. TLR3 signals
via the adaptor protein Trif (Yamamoto
et al., 2003), and so the authors knocked
down TLR3 or Trif and found inhibition of
the induction of pluripotency genes by, October 26, 2012 ª2012 Elsevier Inc. 471
Figure 1. Nuclear Reprogramming by TLR3 Activation and OSKM
Administration of cell-permeant versions of the transcription factors Oct4, Klf4,
Sox2, and c-Myc in combination with TLR3 stimulation with poly I:C induces
nuclear reprogramming in fibroblasts, giving rise to induced pluripotent stem
cells. The same effect can be achieved by transfection of fibroblasts with
a retroviral vector encoding the proteins, the retroviral vector also acting via
TLR3. The effect of TLR3 is to activate NF-kappaB and IRF3 via the adaptor
Trif. The NF-kappaB pathway leads to chromatin modification, including
induction of histone acetyltransferases, histone methyltransferase, decreased
expression of HDACs, H3K4 histone methyltransferase, and H3K79 histone
methyltransferase. IRF3 might mediate it’s effects via type I interferons and
Trims, which silence endogenous retroelements. The combination of OSKM
and TLR3 activation is needed for increased H3K4 methylation and decreased
H3K9 methylation of the promoters for nuclear reprogramming genes regu-
lated by OSKM, as well as HP1 redistribution. The OSKM reprogramming
proteins are therefore needed to direct the epigenetic modifiers activated by
TLR3 to the appropriate promoter sequences to induce genes involved in
nuclear reprogramming and generation of iPSCs.the retrovirally encoded Oct4.
Knockdown of both TLR3 and
Trif also blocks the induction
of human induced pluripotent
stem cells (iPSCs) by retro-
viral reprogramming in fibro-
blasts, as assessed mor-
phologically 30 days after
transfection. This important
result indicates that TLR3
activation can induce human
iPSCs by using the approach
first described by Yamanaka.
The effect of TLR3 activation
is also evident with modified
messenger RNA (mmRNA)-
encoded OSKM. The authors
then tested a synthetic TLR3
agonist, poly I:C. This has
the same effect as the retro-
viral particles, which dramati-
cally accelerates the develop-
ment of iPSCs in fibroblasts




hypothesized that TLR3 acti-
vation might lead to epige-
netic modification, and found
that fibroblasts treated with
retrovirally encoded Sox2 or
cell-permeant Sox2 in the
presence of poly I:C induce
H3K4 trimethylation at the
Oct4 promoter indicative of
an open chromatin state,
the Oct4 gene being a targetfor Sox2. H3K9 methylation of the Oct4
promoter, which is indicative of gene
silencing, was decreased. Poly I:C also
downregulates expression of histone de-
acetylase (HDAC) genes, consistent with
the opening of chromatin structure, since
HDACs via deacetylation of chromatin
are associated with a closed chromatin
state. Poly I:C also accelerates redistri-
bution of heterochromatin protein 1,
a protein that consolidates chromatin
repression, consistent with genome-
wide epigenetic alterations promoted by
TLR3. Both NF-kappaB and IRF3, two
well-known signals activated by TLR3,
are also shown to be involved in the
induction of pluripotency in response
to TLR3 activation, since knockdown
of IRF3 or blockade of NF-kappaB
both inhibit this response. Poly I:C also472 Cell 151, October 26, 2012 ª2012 Elseviinduces changes in expression of a
whole host of enzymes involved in chro-
matin modification, consistent with the
mechanism of action of poly I:C being
to induce epigenetic changes in the
genome to allow OSKM to reprogram
gene expression and induce pluripo-
tency. One of these enzymes, H3K79
histone methyltransferase (Dot1L) is sup-
pressed by poly I:C, and the inhibition of
this enzyme has previously been shown
to be critical for somatic cell reprogram-
ming (Onder et al., 2012). Importantly,
the histone modifications on the Oct4
and Sox2 promoters and the heterochro-
matin protein 1 redistribution are only
seen when poly I:C is coadministered
with the cell-permeant proteins, indi-
cating that the reprogramming proteins
are needed to direct the epigeneticer Inc.modifiers to the appropriate
promoter sequences.
As the authors themselves
therefore state, this study
has serendipitously found a
role for innate immune sig-
naling in nuclear reprogram-
ming leading to the induction
of pluripotent stem cells from
somatic cells. TLR3 plays an
important role in the recogni-
tion of double-stranded RNA
from retroviruses and acti-
vates a signaling pathway
culminating in the induction
of a wide range of antiviral
proteins (Onder et al., 2012).
Epigenetic modification of
chromatin by TLRs has been
reported before (Medzhitov
and Horng, 2009) and is
presumably important for the
increase in expression of
host defense genes during
infection. Here, however, this
epigenetic response is being
deployed to allow for nuclear
reprogramming by OSKM in
a manner potentially safer
than one using retrovirally en-
coded proteins. It is likely that
other innate immune recep-
tors will have a similar effect.
Because the adaptor Trif is
shown to be involved, it is
possible that TLR4, which
senses lipopolysaccharides
(LPS) from gram negativebacteria and also signals via Trif (Yama-
moto et al., 2002), might be capable of
inducing a similar response. Key down-
stream responses of TLR3 and TLR4
signaling include the type I interferons,
and these might also play a role here, in
which case other innate receptors that
can induce type I interferons, such as
the single-stranded RNA sensor RIG-I
(Yoneyama et al., 2004), or DNA sensors,
such as IFI16 (Unterholzner et al., 2010),
might also have a function similar to TLR3.
These other receptors are therefore
worth exploring, and, because they are
all proinflammatory, inspired the authors
to coin the term ‘‘transflammation’’ to
describe the potential of these epigenetic
modifiers to induce pluripotency.
Whatever emerges, this discovery
represents a new beginning in the effort
to develop a safe and effective protocol to
create induced pluripotent stem cells.
Time will tell if this protocol will have clin-
ical utility in this important area of biomed-
ical research.REFERENCES
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Humans are uniquely susceptible to typhoid fever caused by infection with Salmonella enterica
serovar Typhi. Mathur et al. now report that mice lacking Toll-like receptor 11, which is absent in
humans, can be lethally infected with S. Typhi, a breakthrough that promises to speed the develop-
ment of better vaccines.Typhoid fever is a global health pro-
blem estimated to cause more than
20,000,000 infections each year, resulting
in more than 200,000 deaths (Crump
et al., 2004). Although much has been
learned about the pathogenesis of Salmo-
nella infections in recent decades,
studying S. Typhi has remained a chal-
lenge due to its exquisite specificity for
the human host. In this issue, Mathur
et al. (2012) report the breakthrough
discovery that mice lacking the innate
immunity receptor TLR11 can be lethally
infected with S. Typhi via an oral route of
infection. This promises to expand our
understanding of typhoid pathogenesis
and speed the development of better
typhoid vaccines.
The clinical manifestations of typhoid
are distinct from those of otherSalmonella
serovars such as S. Typhimurium, which
typically cause self-limiting inflammatory
diarrhea. In contrast, S. Typhi causes adebilitating systemic illness following a
prolonged incubation period with absent
or mild gastrointestinal symptoms (Parry
et al., 2002). Immunity to nontyphoidal
and typhoidal infections also appears to
differ in fundamental respects, as individ-
uals with chronic granulomatous disease,
HIV infection, or other impairment of
the interferon-g/interleukin-12 (IFNg/IL-
12) signaling axis exhibit enhanced
susceptibility to nontyphoidal salmonel-
losis, but not to typhoid fever (Gordon,
2008). The S. Typhi genome shows the
presence of a number of putative and
confirmed virulence determinants, such
as the Vi capsular polysaccharide and
typhoid toxin, that are not found in
S. Typhimurium. Conversely, there is also
evidence of considerable genomic decay
inS. Typhi, with a large number of pseudo-
genes that have presumably undergone
mutation following the evolutionary adap-
tation of S. Typhi to a narrow host range(Parkhill et al., 2001). It is generally
assumed that genomic decay resulted in
the loss of factors conferring resistance
to host defense mechanisms that are
absent in humans but present in other
mammalian species. However, the iden-
tity of such host defense mechanisms
has remained an enigma.
TLR11 is a Toll-like innate immune
receptor that is expressed by mice, but
not by humans. A previous study reported
that TLR11 recognizes the parasitic
protein profilin and regulates immune
responses to Toxoplasma gondii (Yaro-
vinsky et al., 2005). The new study shows
that TLR11, like another Toll-like receptor
called TLR5, can also recognize bacterial
flagellar protein. TLR11 is highly ex-
pressed at mucosal surfaces, such as
the bladder and intestinal epithelium, but
is also expressed in viscera such as the
liver and spleen and by macrophages,
particularly in the absence of TLR5., October 26, 2012 ª2012 Elsevier Inc. 473
